Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Ivarmacitinib at both 4 mg and 8 mg doses was found to be efficacious in treating alopecia areata in a phase 3 trial.

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the ...

In this Healio Video Perspective from Telling It Like It Is, I. Paul Singh, MD, shares how Dextenza can decrease the topical drop burden of steroids and improve efficiency of ophthalmic surgery.

Primary care clinicians are often the most accessible to patients and play a crucial role in the early detection and ...

Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...

Maternal stress is a major risk factor for preterm birth (PTB), with recent mouse studies highlighting the role of FKBP51 in stress-induced PTB. This study identifies the 15dPGJ2-mediated inhibition ...

Failure to suppress cortisol levels below 50 nmol/l after low dose dexamethasone (0.5 mg every 6 h for eight doses ending at 0300 h, or 1 mg at 2300 h with serum cortisol measured the following ...

Even though the Pixel 8 range is no longer the latest and greatest from Google, we'd say they're still an amazing buy for 2025. Deals have included massive discounts of up to $440 at Mint Mobile ...

Used clinically since the 1920s, corticosteroids interrupt multiple steps in immune activation because of the ubiquitous expression of corticosteroid receptors. Corticosteroids inhibit antigen ...